Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept Monotherapy vs Methotrexate Monotherapy for Maintenance of Remission in RA
NCT02373813Phase 3Completed
- Sponsor
- Amgen
- Start
- Feb 2015
- Primary completion
- Dec 2019
- Modality
- Fc-Fusion Proteins
- Countries
- 15
01
Overview
A Phase 3 trial of etanercept in rheumatoid arthritis (RA), sponsored by Amgen. Started Feb 2015; status: completed.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02373813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02373813.